Abstract
Nearly 500 million individuals are affected by diabetes worldwide. This very high prevalence is combined with a North-South gradient and a seasonality of diagnostics which all suggest the role of climate in diabetes etiology. However, only little is known about the impact of climate on diabetes. This article aims to understand the association of climatic variables with type 1 and type 2 diabetes (T1D and T2D) for 72 countries worldwide (1989-2021). T1D is, on average, more prevalent at extreme latitudes whereas T2D prevalence is higher near equator (P < 0,001). Sunshine, temperature, solar irradiance and daylength (photoperiod) are negatively associated with T1D prevalence and positively associated with T2D in simple regression (P < 0,001). Multicollinearity of climatic variables is considered as a challenge, and it is assessed with VIF and optimized with multiple regression. After adjustment, only photoperiod is associated with T1D prevalence (r2=0,45) and sunshine with T2D prevalence (r2=0,48). T1D monthly incidences are approximated with a cosine regression (RR=1,53) which is significantly associated with photoperiod along the year in Europe (P < 0,05). The relation between photoperiod and T1D has never been reported before in an ecological study and a short review is developed in the discussion.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work began with a Molson-Bombardier grant and a merit grant from the faculty of medicine, university of Montreal.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
- https://diabetesatlas.org/atlas/tenth-edition/; International Diabetes Federation - https://data.worldbank.org/indicator/SP.POP.TOTL?locations=ID; Worldbank - https://worldmap.harvard.edu/data/ WorldMap Harvard data - https://data.un.org/Data.aspx?d=CLINO&f=ElementCode%3a15; Global Historical Climatology Network Daily (GHCND) from the NOAA
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam.